Related Experiment Video
Updated: Jul 9, 2025

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
Unveiling OSCP as the potential therapeutic target for mitochondrial dysfunction-related diseases
Mingyue Zhang1, Xia Luo1, Binzhi Zhang1
1Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine (Institute of Chinese Medicine), Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangdong Provincial Key Laboratory of Chinese Medicine for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Abstract:
Mitochondria are important organelles in cells responsible for energy production and regulation. Mitochondrial dysfunction has been implicated in the pathogenesis of many diseases. Oligomycin sensitivity-conferring protein (OSCP), a component of the inner mitochondrial membrane, has been studied for a long time. OSCP is a component of the F1Fo-ATP synthase in mitochondria and is closely related to the regulation of the mitochondrial permeability transition pore (mPTP). Studies have shown that OSCP plays an important role in cardiovascular disease, neurological disorders, and tumor development. This review summarizes the localization, structure, function, and regulatory mechanisms of OSCP and outlines its role in cardiovascular disease, neurological disease, and tumor development. In addition, this article reviews the research on the interaction between OSCP and mPTP. Finally, the article suggests future research directions, including further exploration of the mechanism of action of OSCP, the interaction between OSCP and other proteins and signaling pathways, and the development of new treatment strategies for mitochondrial dysfunction. In conclusion, in-depth research on OSCP will help to elucidate its importance in cell function and disease and provide new ideas for the treatment and prevention of related diseases.
Insights
Oligomycin sensitivity-conferring protein (OSCP) is vital for mitochondrial function and linked to diseases. Research highlights OSCP's role in cardiovascular, neurological, and tumor development, suggesting new therapeutic avenues.
Area of Science:
- Mitochondrial biology and cellular energy regulation.
Background:
- Mitochondrial dysfunction is central to numerous diseases.
- Oligomycin sensitivity-conferring protein (OSCP) is a key component of the F1Fo-ATP synthase.
- OSCP is implicated in regulating the mitochondrial permeability transition pore (mPTP).
Purpose of the Study:
- To review the localization, structure, function, and regulation of OSCP.
- To outline OSCP's involvement in cardiovascular disease, neurological disorders, and cancer.
- To explore the interaction between OSCP and mPTP.
Main Methods:
- Literature review of existing studies on OSCP.
- Analysis of OSCP's role in various disease models.
- Examination of OSCP's interaction with the mPTP.
Main Results:
- OSCP plays a significant role in cardiovascular disease, neurological disorders, and tumor progression.
- OSCP is closely linked to the regulation of the mitochondrial permeability transition pore.
- Existing research provides a foundation for understanding OSCP's multifaceted functions.
Conclusions:
- Further research into OSCP's mechanisms, interactions, and therapeutic potential is warranted.
- Understanding OSCP is crucial for developing novel treatments for mitochondrial dysfunction-related diseases.
- In-depth study of OSCP offers new strategies for disease prevention and treatment.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
ATP Synthase: Mechanism
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

